Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsA new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterizationThe Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future PerspectivesAntibodies as Mediators of Brain PathologyImmunology of neuromyelitis optica: a T cell-B cell collaborationAquaporins in the Spinal CordImaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple SclerosisQuantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot StudyEvaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serologyThe expanded spectrum of neuromyelitis optica: evidences for a new definition.Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Mechanisms of Autoantibody-Induced Pathology.Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumabGlycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesThe use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritisAquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studiesAquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays.Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevanceLow levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.Autoimmune channelopathies: new antibody-mediated disorders of the central nervous systemAntibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization.Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificityUpdate on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?Brain-reactive antibodies and disease.New insights into neuromyelitis opticaCentral Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional StudyComplement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disordersAquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMOSerologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
P2860
Q21093230-A71939FB-DCB0-4F91-A03E-4FEB8AFCB338Q21245233-6727AB58-E104-470A-8B72-74CCD9993FE5Q26767391-40BA4D84-D558-4B1F-AB3E-982DD8796D03Q26780374-69676148-A001-459B-BB24-89407C6DC121Q27016045-919FC742-5CEA-485B-B7A6-D35D1B395E3AQ28066783-1B39FE76-D3F2-4170-A3BB-D56C09AC90F3Q28267527-4B6DE375-F348-4922-958D-EA2E9F26CE65Q28552020-1FD06B88-F377-4E7B-9CB5-FAE193E847DDQ28728565-4782433D-B240-47F6-B467-8FCEF7A5F2EBQ30573084-CE33BB4C-D5D4-465E-B5C3-A8BCF6045C53Q30577078-ECC7B37F-0064-485D-B985-DE689371C509Q30785267-C0DDA6BD-5D40-46A9-9343-C04114461FBCQ33740580-9B8D1079-BB89-4063-A39D-3DC7E9959790Q33770508-69C10658-2EF8-405F-A7BA-57A4B07A2FFAQ33882739-67D51B85-9F81-45E0-87D0-0775429F336DQ33892764-C2BBBD76-AC27-4629-AA29-3F00DF7EC26DQ33895664-89409661-103A-46CF-8788-5211AE42F7F7Q33937492-43AA906F-7164-40C1-ACAF-0D18710E1A71Q34005484-52246DE9-00D3-4DC3-9396-97D37C8DFCC1Q34026880-A94AD49E-8BA7-4004-B3FC-E78F95B78CDCQ34127075-20D95096-EEDE-413C-B4CB-9E966C1AA76AQ34138884-13AB82ED-CA0B-424F-B4BF-C845C7CA860FQ34154277-3F2B76C4-EED3-44A2-8AC0-D27042D70BDBQ34166367-B9C96ECA-D882-4CA8-8726-8A815536139EQ34167246-DB7F362F-BC5E-49C8-85F2-04A841AC0379Q34206885-9A062CCF-C731-47E9-9979-D810D048F24FQ34460610-6BDEFB2C-52BF-46FF-81B6-97B4986AD6A5Q34497097-472B36B8-8F3E-48DF-97F2-E447A76C8638Q34513731-760A4394-02DE-4FD9-811C-1946FD998DFBQ34990974-B8837BE1-0989-4CF3-BCE1-74F77419E207Q35048235-F30126D0-29A4-47F0-95A2-E3C0CBF1AFF7Q35052199-57D2BFA1-F00A-4AF7-B60C-3621A35A2AA8Q35072715-0A040A18-DC2D-4E5E-9F23-302B0D26A8D9Q35081997-E2E76125-2CFA-4693-9FDB-E77129E7A784Q35458567-22428F06-8FC7-4F3C-A39A-DE06EDDDE19CQ35539641-CAE7E13D-29C3-4C59-9971-AA4C4B787ADFQ35722940-AC814B2F-05C5-4A84-B515-5CCC3153FE45Q35753620-BC18E598-2696-473C-82EE-EC899623BB40Q35764733-CF429025-9FF8-45F1-B0B2-BAF0FDCEEE0AQ35776490-5FF413E8-1603-4000-815C-D3782E5DE65F
P2860
Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Aquaporin-4 antibodies in neur ...... extensive transverse myelitis.
@en
Aquaporin-4 antibodies in neur ...... extensive transverse myelitis.
@nl
type
label
Aquaporin-4 antibodies in neur ...... extensive transverse myelitis.
@en
Aquaporin-4 antibodies in neur ...... extensive transverse myelitis.
@nl
prefLabel
Aquaporin-4 antibodies in neur ...... extensive transverse myelitis.
@en
Aquaporin-4 antibodies in neur ...... extensive transverse myelitis.
@nl
P2093
P1433
P1476
Aquaporin-4 antibodies in neur ...... extensive transverse myelitis.
@en
P2093
Bryony Gray
David Beeson
Edward Littleton
Maria Isabel Leite
Patrick Waters
Ruth Geraldes
Saiju Jacob
Susan Maxwell
Sven Jarius
P304
P356
10.1001/ARCHNEUR.65.7.913
P577
2008-07-01T00:00:00Z